March 24, 2018Comments Off on New patent expiration for Galderma Labs drug CLOBEX Posted in: Uncategorized

Annual Drug Patent Expirations for CLOBEX Clobex is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in three NDAs. It is available from five suppliers.… The post New patent expiration for Galderma Labs drug CLOBEX appeared f…

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. This ingredient… The post New tentative approval for Watson Labs dr…

Share this:

Like this:

March 24, 2018Comments Off on Pharmaceutical companies with the most ‘Pediatric Exclusivity’ drugs Posted in: Infographic

This chart shows the companies which have received the most pediatric exclusivities in the past five years. Pediatric exclusivity is granted to drug companies for conducting pediatric studies on their… The post Pharmaceutical companies with the m…

Share this:

Like this:

March 23, 2018Comments Off on New patent expiration for Covis Pharma drug ALTOPREV Posted in: Uncategorized

Annual Drug Patent Expirations for ALTOPREV Altoprev is a drug marketed by Covis Pharma Bv and is included in one NDA. It is available from one supplier. There is one… The post New patent expiration for Covis Pharma drug ALTOPREV appeared first o…

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. This ingredient… The post New tentative approval for Watson Labs dr…

Share this:

Like this:

March 23, 2018Comments Off on Which pharmaceutical companies have the most drug patents in Norway? Posted in: Infographic

This chart shows the pharmaceutical companies with the most patents in Norway. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug…

Share this:

Like this:

March 21, 2018Comments Off on Obstacles and opportunities in Chinese pharmaceutical innovation Posted in: Insights

This article was originally published by Jingyun Ni, Junrui Zhao, Carolina Oi Lam Ung, Yuanjia Hu, Hao Hu and Yitao Wang in Globalization and Health201713:21 under a Creative Commons License. Abstract… The post Obstacles and opportunities in Chin…

Share this:

Like this:

March 21, 2018Comments Off on New patent for Sunovion Pharms drug LATUDA Posted in: Patent Added

Annual Drug Patent Expirations for LATUDA Latuda is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are nine… The post New patent for Sunovion Pharms drug LATUDA appeared first on DrugPa…

Share this:

Like this:

March 21, 2018Comments Off on New patent expiration for Schering drug REBETOL Posted in: Uncategorized

Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. It is available from one supplier. There… The post New patent expiration for Schering drug REBETOL appeared first…